Enzymotec Ltd (NASDAQ:ENZY)

7.01
Delayed Data
As of Mar 27
 +0.01 / +0.14%
Today’s Change
5.38
Today|||52-Week Range
22.46
-8.25%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$157.7M

Company Description

Enzymotec Ltd. is a nutritional ingredients and medical foods company, together with its subsidiaries, develops, manufactures, markets and sells innovative bio-functional lipid ingredients, as well as final products, based on sophisticated proprietary processes and technologies. The company operates through two segments: Nutrition and VAYA Pharma. The Nutrition segment develops and manufactures nutritional ingredient products based on lipids, such as phospholipids. The VAYA Pharma segment develops, manufactures and sells medical foods for the dietary management of patients with certain medical conditions or diseases having special, medically determined nutrient requirements. Enzymotec was founded by Sobhi Basheer and Daniel C. Plotkin on March 8, 1998 and is headquartered in Migdal HaEmeq, Israel.

Contact Information

Enzymotec Ltd.
Sagi 2000 Industrial Park
Migdal HaEmeq -- 23106
P:972747177177
Investor Relations:

Employees

Shareholders

Mutual fund holders6.81%
Other institutional34.76%
Individual stakeholders--

Top Executives

Ariel KatzPresident & Chief Executive Officer
Yoni TwitoChief Operations Officer
Oren BryanChief Financial Officer & Vice President
Ariel BlumovichVice President-Business Development
Yariv GratzVice President-Operations

To view my watchlist

Not a member yet?

Sign up now for a free account